Steris | STE - Sales Revenues


Steris reported $1.5B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
3M USD 6B 100M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
Avanos Medical USD 182.2M 1.3M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
CONMED USD 317M 56.2M Mar/2026
Cooper Companies USD 1.02B 41.1M Dec/2025
Dexcom USD 1.19B 70M Mar/2026
Ecolab USD 4.07B 120M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fortive USD 1.07B 50M Mar/2026
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 826.4M 57.4M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Idexx Laboratories USD 1.14B 50M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 391.9M 43M Mar/2026
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Masimo USD 412.5M 41M Dec/2025
Olympus JPY 261.05B 13.21B Dec/2025
Orthofix International USD 219.91M 14.28M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
ResMed USD 1.4B 0 Mar/2026
Steris USD 1.5B 470M Dec/2025
Stryker USD 6B 1.2B Mar/2026
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026